共 50 条
- [41] Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 942 - 943
- [42] Rituximab in Patients With Phospholipase A2 Receptor-Associated Membranous Nephropathy and Severe CKD KIDNEY INTERNATIONAL REPORTS, 2020, 5 (03): : 331 - 338